Texas Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Technology Digest.

Press releases published on July 2, 2026

Jul. 2, 2026

iDVI, powered by Autoflow, announces its rebranding to reflect product growth

Indeterminate EIN Presswire

Jul. 2, 2026

McClain Bank Partners with Zelus to Modernize New Account Opening with SNAP

Indeterminate EIN Presswire

Jul. 2, 2026

Lightspeed Systems Introduces AI Governance Dashboard to Help K-12 Districts Manage Student AI Use

Indeterminate EIN Presswire

Jul. 2, 2026

Audyence and Demandbase Launch First Native Integration for B2B Lead Generation

Indeterminate EIN Presswire

Jul. 2, 2026

Chinese inventors Xie Yinghao and Yu Haijun secure dual win at the European Inventor Award 2026 for smart battery recycling

Indeterminate GlobeNewswire

Jul. 2, 2026

中国发明人谢英豪、余海军凭借智能电池循环技术斩获2026年欧洲发明家奖双项殊荣

Indeterminate GlobeNewswire

Jul. 2, 2026

Herb Meiner's Rock It Like Herb Unveils a New Episode on Leadership, Innovation, and Transparency

Indeterminate GlobeNewswire

Jul. 2, 2026

Alarum Technologies Responds to Inquiry into Residential Proxy Networks

Indeterminate GlobeNewswire

Jul. 2, 2026

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

VivoPower Reinforces Focus on AI Data Center Business and Provides Update on Non-Core Businesses

Indeterminate GlobeNewswire

Jul. 2, 2026

Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.

Indeterminate GlobeNewswire

Jul. 2, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Jul. 2, 2026

Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire